Summary:
The purpose of this study is to evaluate the safety, effectiveness and tolerability of a medication (compared to placebo) to treat impulsive aggression in children and adolescents with ADHD.
Qualified Participants Must:
• Be 7 - 17 years of age
•
Have been diagnosed with ADHD and take an approved medication to help manage those symptoms
•
Have episodes of impulsive aggression (e.g., yelling, hitting, kicking, breaking items, etc.)
•
Weight at least 44 pounds, with a BMI less than 99%
•
Able and willing to swallow whole tablets
•
Be physically healthy (other than diagnosis of ADHD)
Qualified Participants May Receive:
All study-related visits, tests, and drugs will be provided at no cost. In addition, reimbursement for study-related travel may be provided